Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 2866 AL 2880

Intranasal Insulin Reduces White Matter Hyperintensity Progression in Association with Improvements in Cognition and CSF Biomarker Profiles in Mild Cognitive Impairment and Alzheimer's Disease

Kellar D, Lockhart SN, Aisen P, Raman R, Rissman RA, Brewer J, Craft S.

J Prev Alzheimers Dis. 2021;8(3):240-248. doi: 10.14283/jpad.2021.14.

Lithium: A therapeutic option in Alzheimer's disease and its prodromal stages?

Haussmann R, Noppes F, Brandt MD, Bauer M, Donix M.

Neurosci Lett. 2021 Aug 24;760:136044. doi: 10.1016/j.neulet.2021.136044. Epub 2021 Jun 10.

Combination of Plasma Neurofilament Light Chain and Mini-Mental State Examination Score Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease within 5 Years

Darmanthé N, Tabatabaei-Jafari H, Cherbuin N; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2021;82(3):951-964. doi: 10.3233/JAD-210092.

The Influence of Serum Uric Acid Level on Alzheimer's Disease: A Narrative Review

Qiao M, Chen C, Liang Y, Luo Y, Wu W.

Biomed Res Int. 2021 Jun 2;2021:5525710. doi: 10.1155/2021/5525710. eCollection 2021.

Cerebrospinal fluid lipidomics for biomarkers of Alzheimer's disease

Byeon SK, Madugundu AK, Jain AP, Bhat FA, Jung JH, Renuse S, Darrow J, Bakker A, Albert M, Moghekar A, Pandey A.

Mol Omics. 2021 Jun 14;17(3):454-463. doi: 10.1039/d0mo00186d.

Anosognosia in dementia with Lewy bodies: a systematic review

Calil V, Sudo FK, Santiago-Bravo G, Lima MA, Mattos P.

Arq Neuropsiquiatr. 2021 Apr;79(4):334-342. doi: 10.1590/0004-282X-ANP-2020-0247.

Cellular Senescence and ApoE4: Their Repercussions in Alzheimer's Disease

Tecalco-Cruz AC, Zepeda-Cervantes J, López-Canovas L, Ramírez-Jarquín JO, Pedraza-Chaverrí J, Briones-Herrera A.

CNS Neurol Disord Drug Targets. 2021;20(9):778-785. doi: 10.2174/1871527320666210628102721.

Copper Imbalance in Alzheimer's Disease: Meta-Analysis of Serum, Plasma, and Brain Specimens, and Replication Study Evaluating ATP7B Gene Variants

Squitti R, Ventriglia M, Simonelli I, Bonvicini C, Costa A, Perini G, Binetti G, Benussi L, Ghidoni R, Koch G, Borroni B, Albanese A, Sensi SL, Rongioletti M.

Biomolecules. 2021 Jun 29;11(7):960. doi: 10.3390/biom11070960.

Blood biomarkers for the diagnosis of amnestic mild cognitive impairment and Alzheimer's disease: A systematic review and meta-analysis

Qu Y, Ma YH, Huang YY, Ou YN, Shen XN, Chen SD, Dong Q, Tan L, Yu JT.

Neurosci Biobehav Rev. 2021 Sep;128:479-486. doi: 10.1016/j.neubiorev.2021.07.007. Epub 2021 Jul 7.

Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study

Fagan AM, Henson RL, Li Y, Boerwinkle AH, Xiong C, Bateman RJ, Goate A, Ances BM, Doran E, Christian BT, Lai F, Rosas HD, Schupf N, Krinsky-McHale S, Silverman W, Lee JH, Klunk WE, Handen BL, Allegri RF, Chhatwal JP, Day GS, Graff-Radford NR, Jucker M, Levin J, Martins RN, Masters CL, Mori H, Mummery CJ, Niimi Y, Ringman JM, Salloway S, Schofield PR, Shoji M, Lott IT; Alzheimer's Biomarker Consortium–Down Syndrome; Dominantly Inherited Alzheimer Network.

Lancet Neurol. 2021 Aug;20(8):615-626. doi: 10.1016/S1474-4422(21)00139-3.

Diabetes mellitus contributes to higher cerebrospinal fluid tau levels selectively in Alzheimer's disease patients with the APOE4 genotype

Motta C, Assogna M, Bonomi CG, Mascolo AP, De Lucia V, Semprini R, Mercuri NB, Koch G, Martorana A.

Eur J Neurol. 2021 Dec;28(12):3965-3971. doi: 10.1111/ene.15039. Epub 2021 Aug 9.

Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes

Mielke MM, Frank RD, Dage JL, Jeromin A, Ashton NJ, Blennow K, Karikari TK, Vanmechelen E, Zetterberg H, Algeciras-Schimnich A, Knopman DS, Lowe V, Bu G, Vemuri P, Graff-Radford J, Jack CR Jr, Petersen RC.

JAMA Neurol. 2021 Sep 1;78(9):1108-1117. doi: 10.1001/jamaneurol.2021.2293.

Mediterranean and Western diet effects on Alzheimer's disease biomarkers, cerebral perfusion, and cognition in mid-life: A randomized trial

Hoscheidt S, Sanderlin AH, Baker LD, Jung Y, Lockhart S, Kellar D, Whitlow CT, Hanson AJ, Friedman S, Register T, Leverenz JB, Craft S.

Alzheimers Dement. 2022 Mar;18(3):457-468. doi: 10.1002/alz.12421. Epub 2021 Jul 26.

Comparison of CSF phosphorylated tau 181 and 217 for cognitive decline

Mielke MM, Aakre JA, Algeciras-Schimnich A, Proctor NK, Machulda MM, Eichenlaub U, Knopman DS, Vemuri P, Graff-Radford J, Jack CR Jr, Petersen RC, Dage JL.

Alzheimers Dement. 2022 Apr;18(4):602-611. doi: 10.1002/alz.12415. Epub 2021 Jul 26.

Therapeutic plasma exchange with albumin: a new approach to treat Alzheimer's disease

Boada M, Martínez-Lage P, Serrano-Castro P, Costa M, Páez A.

Expert Rev Neurother. 2021 Aug;21(8):843-849. doi: 10.1080/14737175.2021.1960823. Epub 2021 Aug 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias